
Diego A. Díaz García/X
May 4, 2025, 09:00
HER2 testing is evolving fast – Diego A. Díaz García
Diego A. Díaz García, Medical Oncologist, Fellow in Thoracic Oncology at National Cancer Institute of Mexico, shared on X:
“HER2 testing is evolving fast.
•The evolution of HER2 testing methodologies.
•Current guidelines across tumor types.
•Challenges with IHC and FISH in HER2-low settings.
•The promise of quantitative and RNA-based assays.”
Title: HER2 testing: evolution and update for a companion diagnostic assay
Authors: Charles J. Robbins, Katherine M. Bates and David L. Rimm
Find More Posts Featuring HER2 testing on OncoDaily
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 4, 2025, 09:00
May 4, 2025, 08:54
May 4, 2025, 08:36
May 4, 2025, 08:21
May 4, 2025, 07:25
May 4, 2025, 07:25